AAP
ARTC

Ardsley Advisory Partners’s ARTHROCARE CORP ARTC Stock Holding History

Ardsley Advisory Partners’s Portfolio ARTC Stock Details ARTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-470,000
Closed -$18.9M – 303
2013
Q4 		$18.9M Buy
470,000
+26,000
+6% +$963K 2.51% 11
2013
Q3 		$15.8M Buy
444,000
+196,500
+79% +$6.86M 3.23% 6
2013
Q2 		$8.55M Buy
+247,500
New +$8.51M 1.88% 20

Other funds holding ARTC

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ardsley Advisory Partners's ARTC Position: Q1 2014 in Review

Ardsley Advisory Partners sold out of ARTHROCARE CORP (ARTC) in Q1 2014, closing a stake of 470,000 shares — an estimated $18.9M sold.

Ardsley Advisory Partners first reported a position in ARTC in Q2 2013 and held it in 3 quarters. The position peaked at $18.9M in Q4 2013. 117 funds tracked by Wall St. Rank hold ARTC as of Q1 2014.

  • Ardsley Advisory Partners reported no remaining ARTHROCARE CORP position as of Q1 2014 after selling out during the quarter.
  • Ardsley Advisory Partners sold 470,000 ARTHROCARE CORP shares in Q1 2014, an estimated $18.9M.
  • Ardsley Advisory Partners first reported a position in ARTHROCARE CORP in Q2 2013 and held it in 3 quarters.
  • Ardsley Advisory Partners's ARTHROCARE CORP position peaked at $18.9M in Q4 2013.
  • 117 funds tracked by Wall St. Rank held ARTHROCARE CORP as of Q1 2014.

Based on Ardsley Advisory Partners's 13F filing for Q1 2014, filed 15 May 2014.